
Profile
General Information
Astelin nasal spray has been approved for the treatment of symptoms associated with seasonal allergic rhinitis.
It offers a valuable treatment option for the estimated 20-40 million Americans who suffer from seasonal allergic rhinitis, the fifth most common chronic illness that causes millions of lost work days and significant discomfort for the sufferer.
Approval Date: 1996-11-01
Company Name: Wallace Laboratories